Skip to main content
· 5/8/2003

SmithKline Beecham Corp. v. Pentech Pharmaceuticals, Inc.

Citations

  • 261 F. Supp. 2d 1002
  • 55 Fed. R. Serv. 3d 888
  • 2003 U.S. Dist. LEXIS 7854
  • 2003 WL 21058505

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • determining that the court could consider “whether the settlement agreement might cause ‘plain legal prejudice’” to a non-settling defendant but could not opine on whether the voluntary settlement was contrary to public policy in the context of a 41(a)(2) motion
  • determining that the court could consider “whether the settlement agreement might cause ‘plain legal prejudice’” to a non-settling defendant but could not opine on whether the voluntary settlement was contrary to public policy in the context of a 41(a)(2) motion
  • determining that the court could consider “whether the settlement agreement might cause ‘plain legal prejudice’” to a non-settling defendant but could not opine on whether the voluntary settlement was contrary to public policy in the context of a 41(a)(2) motion
  • maintaining a document under seal where public disclosure of the information would effectively afford other firms an unearned competitive advantage

Source: CourtListener parenthetical corpus (CC0).

Judges: Posner

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.